Stocks and Investing Stocks and Investing
Thu, March 25, 2021
Wed, March 24, 2021
Tue, March 23, 2021
Mon, March 22, 2021
Fri, March 19, 2021
Thu, March 18, 2021

Edward Nash Maintained (AKRO) at Strong Buy with Decreased Target to $46 on, Mar 18th, 2021


Published on 2024-10-27 15:59:20 - WOPRAI, Edward Nash
  Print publication without navigation


Edward Nash of Canaccord Genuity, Maintained "Akero Therapeutics, Inc." (AKRO) at Strong Buy with Decreased Target from $51 to $46 on, Mar 18th, 2021.

Edward has made no other calls on AKRO in the last 4 months.



There are 3 other peers that have a rating on AKRO. Out of the 3 peers that are also analyzing AKRO, 0 agree with Edward's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Edward


  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $61 on, Wednesday, March 17th, 2021
  • Michael Morabito of "Chardan Capital" Maintained at Strong Buy with Increased Target to $81 on, Wednesday, March 17th, 2021
  • Etzer Darout of "Guggenheim" Initiated at Strong Buy and Held Target at $54 on, Friday, February 26th, 2021